Kaman to be Acquired by Arcline for $1.8 Billion
Arcline acquires KAMAN, in an all-cash transaction with a total enterprise value of approximately $1.8 billion. KAMAN will become a a private held company, upon completion of the transaction. Arcline is a growth-oriented private equity firm with deep experience investing in technology-driven, meaningful-to-the-world industrial businesses. “Following robust engagement with Arcline and careful evaluation of other […]
Blackstone makes first investment in Japan’s fintech sector
Blackstone is seizing this opportunity by acquiring a majority stake in Sony Payments Services (SPSV) from Sony Bank, a subsidiary of Sony Group. The deal was announced in December. It marks the private equity firm’s first investment in the financial technology sector in Japan. Sony Bank, which established the payment service business in 1995 and […]
BlackRock bets on infrastructure in $12.5bn deal
BlackRock has agreed to acquire Global Infrastructure Partners, a New York City-based infrastructure fund manager, in a $12.5 billion cash-and-stock deal. The GIP management team, led by Bayo Ogunlesi and four of its founding partners, will lead the combined infrastructure platform. BlackRock has also agreed to appoint Bayo Ogunlesi, GIP founding partner, chairman and CEO […]
Goldman Sachs Asset Management raises $650 mln for life sciences fund
Goldman Sachs Asset Management said on Wednesday it had raised $650 million for a new fund that will invest in startups related to the life sciences sector. The fund, West Street Life Sciences I, will specifically target early to mid-stage therapeutic companies with multi-asset portfolios as well as tools and diagnostics firms. “Life sciences represents […]
Blackstone pays $2.4bn for minority stake in NiSource unit
Blackstone’s infrastructure unit has agreed to invest $2.41bn in Northern Indiana Public Service Company, a unit of NiSource. NiSource said an affiliate of Blackstone Infrastructure Partners will pay $2.16bn for a 19.9% indirect non-controlling equity interest in Northern Indiana Public Service Company. Blackstone also made an additional equity commitment of $250m to fund ongoing capital […]
Warburg Pincus surpasses target to close $17bn private equity fund
The US private equity group Warburg Pincus has raised $17.3bn for the largest fund in its 57-year history, joining a handful of peers in that have beat their targets as others struggle to bring in cash. The firm began soliciting investments for the new fund about two years ago with a $16bn target. The fund […]
CAI raises over $1B for inaugural fund and co-investment programme
Climate Adaptive Infrastructure (CAI), an investment firm that targets control investments in large-scale, low-carbon real assets in the clean energy, water, and urban infrastructure sectors, has close of its inaugural fund, Climate Adaptive Infrastructure Fund with more than $825 million in equity. In addition, alongside the Fund, CAI has an affiliated co-investment programme of over […]
Carlyle targeting $1.6B for second renewables fund
Carlyle Group is targeting at least $1.6 billion for a second private equity fund which will focus on investments in renewable energy and sustainability assets, according to a report by Reuters. The report cutes sources familiar with the matter as saying that Carlye began raising capital for Carlyle Renewable & Sustainable Energy Fund II earlier […]
Vista’s latest flagship fund halfway to $20B target
The report cites documents prepared of a US pension fund as showing that Vista Equity Partners VIII, which launched earlier this year, has already passed the halfway mark. A due diligence report by the chief investment officer of Connecticut Retirement Plans and Trust Funds CRTPF, prepared for the pension’s 16 November investment advisory council meeting […]
MVM closes oversubscribed Fund VI at $500m hard cap
MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services […]
